Business Context and Reporting Period
This Form 8-K Current Report from Nutex Health Inc. (NUTX) covers the period ending May 21, 2025, with the earliest event reported on May 15, 2025. The filing addresses a change in the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on governance and audit matters rather than financial performance metrics.
Material Changes
Change in Certifying Accountant
- Dismissal: On May 15, 2025, the Audit Committee dismissed CBIZ CPAs P.C. as the independent registered public accounting firm. CBIZ did not issue an audit report on the Company's financial statements.
- Appointment: Effective May 15, 2025, the Committee appointed Grant Thornton LLP as the new independent registered public accounting firm for the fiscal year ending December 31, 2025.
Internal Control Deficiencies
The Company disclosed material weaknesses in internal control over financial reporting during the three-month period ended March 31, 2025, and through May 15, 2025:
- IT Controls: Ineffective design and operation of controls over logical access, program change management, and vendor management, including inadequate restrictions on system access and failure to properly validate data changes.
- Business Process Controls: Ineffective design across financial reporting processes, specifically lacking proper segregation of duties between preparers and reviewers and insufficient key management review controls.
- Spreadsheet Controls: Ineffective controls over the completeness and accuracy of information in key spreadsheets supporting financial statements.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, revenue outlook, or management commentary regarding future financial performance. The primary risk disclosed is the existence of material weaknesses in internal controls, which may impact the reliability of financial reporting. The Company confirmed no disagreements or reportable events with the new auditor, Grant Thornton, regarding accounting principles or audit opinions.
Investor Verification Checklist
- Verify the status of the remediation plan for the disclosed material weaknesses in IT and financial reporting controls.
- Review the letter from CBIZ CPAs P.C. (Exhibit 16.1) to confirm their agreement with the Company's statements regarding the dismissal.
- Monitor upcoming filings for the impact of the auditor change on the audit timeline for the fiscal year ending December 31, 2025.
- Assess whether the lack of an audit report from CBIZ affects the Company's ability to file timely periodic reports (10-Q/10-K).